Fresenius Medical Care AG (STU:FMEA) Equivalent Admissions #: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:FMEA Fresenius Medical Care AG STU:FMEA
74 GF Score
Price €19.30
GF Value €20.99
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Equivalent Admissions #?

Fresenius Medical Care AG STU:FMEA +0.52% 74 Equivalent Admissions # is 0.00 as of . 20. GuruFocus rates STU:FMEA with a GF Score™ of 74/100 and a GF Value™ of €20.99 (Fairly Valued). The stock has 3 warning signs investors should review.

Equivalent Admissions # are a general measure used to indicate combined inpatient and outpatient volumes.

The historical rank and industry rank for Fresenius Medical Care AG's Equivalent Admissions # or its related term are showing as below:

STU:FMEA's Equivalent Admissions # is not ranked *
in the Healthcare Providers & Services industry.
Industry Median:
* Ranked among companies with meaningful Equivalent Admissions # only.

Fresenius Medical Care AG Equivalent Admissions # Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Equivalent Admissions # can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Equivalent Admissions # Chart


STU:FMEA
74GF Score
Fresenius Medical Care AG STU:FMEA
Equivalent Admissions # is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions
What does a Equivalent Admissions # of 0.00 mean?
Fresenius Medical Care AG (STU:FMEA) has a Equivalent Admissions # of 0.00 as of . 20. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Equivalent Admissions # too high?
Fresenius Medical Care AG's current Equivalent Admissions # is 0.00. Overall, Fresenius Medical Care AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Equivalent Admissions # compare to HCA and THC?
Fresenius Medical Care AG's Equivalent Admissions # of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equivalent Admissions # for a Healthcare Providers & Services company?
A good Equivalent Admissions # depends on the Healthcare Providers & Services industry context. However, Equivalent Admissions # should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equivalent Admissions # mean?
A high Equivalent Admissions # can signal that a stock is expensive relative to its fundamentals. Equivalent Admissions are a general measure used to indicate combined inpatient and outpatient volumes. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Equivalent Admissions # is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (STU:FMEA) is currently considered Fairly Valued. The stock's GF Value™ is €20.99, compared to a current price of €19.30 — trading 8.1% below its estimated fair value. The current Equivalent Admissions # is 0.00. Fresenius Medical Care AG's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equivalent Admissions # calculated?
Equivalent Admissions # is calculated from a company's financial statements. For Fresenius Medical Care AG (STU:FMEA), the current Equivalent Admissions # is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (STU:FMEA) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued. The current stock price of €19.30 is trading 8.1% below its estimated GF Value™ of €20.99. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for STU:FMEA:

  • Equivalent Admissions #: 0.00
  • GF Value™: €20.99 vs. price of €19.30 (8.1% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the STU:FMEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care AG is a German healthcare company focused on kidney care and dialysis. It operates two main segments: Health Care Services, which runs a global network of dialysis clinics treating patients with end-stage renal disease and related conditions, and Health Care Products, which manufactures and sells dialysis machines, dialyzers, filters, concentrates, and related medical technology. The company also provides renal pharmaceuticals, vascular access products, and home dialysis therapies. Services generate the majority of revenue, primarily through reimbursement from public and private payers, while product sales contribute the remainder. Fresenius Medical Care operates clinics and production sites across North America, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, with the United States representing its largest market. The company is headquartered in Bad Homburg, Germany, and its shares trade on the Frankfurt Stock Exchange and the New York Stock Exchange.
74GF Score

Get the complete analysis for STU:FMEA

Equivalent Admissions # is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.30
Price
€20.99
GF Value